Klimek, Ludger
Wehrmann, Wolfgang
Brehler, Randolf
Becker, Sven
Cuevas, Mandy
Gröger, Moritz
Hagemann, Jan
Casper, Ingrid
Sulk, Mathias
Gorris, Senne
Seys, Sven F.
Funding for this research was provided by:
Universitätsklinikum Münster
Article History
Received: 16 April 2024
Accepted: 31 May 2024
First Online: 15 July 2024
Conflict of interest
: L. Klimek reports grants and/or personal fees from Allergopharma, Viatris, HAL Allergy, ALK Abelló, LETI Pharma, Stallergenes, Quintiles, Sanofi, ASIT biotech, Lofarma, Allergy Therapeut, AstraZeneca, GSK, Inmunotek, Cassella med, Novartis, Regeneron Pharmaceuticals, ROXALL Medizin GmbH, outside the submitted work; and membership: AeDA, DGHNO, German Academy of Allergology and Clinical Immunology, HNO-BV, GPA, EAACI; L. Klimek is Editor-in-Chief of Allergo Journal and Allergo Journal International. R. Brehler reports honoraria from ALK, Allergopharma, Bencard, HAL, Leti, Stallergenes, AstraZeneca, GSK, MedUpdate, Novertis, BiotechTools, Genentech and Circassia, outside the submitted work. S. Becker reports grants from Bencard Allergie, BRAIN AG, Karl Storz GmbH, Altamira AG and the German Federal Ministry of Education and Research; honoraria for advisory boards and presentations from Allergy Therapeutics, Bencard Allergie, HAL Allergy, Allergopharma, ALK Abelló, Sanofi, Novartis, GSK, AstraZeneca, MSD, Viatris, Ambu and Stryker. M. Cuevas declares honoraria for presentations from ALK-Abelló, Allergopharma, AstraZeneca, Bencard Allergie/Allergy Therapeutics, GalaxoSmithKline, HAL Allergy, Leti Pharma, Novartis, Roxall, Sanofi-Aventis, Stallergenes, outside the submitted work; other non-financial interests: German Society of Allergy (AeDA), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery DGHNO-KHC. M. Gröger reports grants and lecture fees from ALK-Abelló, Allergopharma, AstraZeneca, Bencard Allergie, Glaxo Smith Kline, HAL Allergie, LETI Pharma, Mylan, Novartis Pharma, Phadia – Thermo Fisher Scientific, Sanofi-Aventis, Shire, and Stallergenes, outside the submitted work. J. Hagemann received speaker honoraria and fees for advisory boards from HAL Allergy, Sanofi Genzyme D GmbH, GlaxoSmithKline (GSK) D GmbH, GSK Global, Novartis Pharma D GmbH, outside the here-submitted work. M. Sulk reports honoraria from AstraZeneca, Bencard, BioCryst, CSL-Behring, HAL Allergie, Leo Pharma, Novartis, Sanofi, Takeda, Unna Akademie, outside the submitted work.S. Gorris and S.F. Seys are employees and shareholders of Hippocreates BV, Aarschot, Belgium. W. Wehrmann and I. Casper declare that they have no competing interests.